Saturday, April 13
8:00 am - 12:00 pm
010 Laser Thermocoagulation (LITT) - How, When and Why
Supported by an educational grant from MRI Interventions
Director(s): Veronica L. Chiang, MD, FAANS
Assistant Director(s): Michael Schulder, MD, FAANS
Faculty: Claudio Tatsui, MD, IFAANS; Stephen B. Tatter, MD, PhD, FAANS; Jessica Wilden, MD, FAANS
MRI-guided Laser Thermal Ablation (MgLTA) is a developing technology with evolving indications. It is currently mostly involved mostly in the treatment of tumors and epilepsy but with possible indications in vascular and spine. It is important for neurosurgeons to understand the advantages, limitations and costs of this new technology and what needs to be studied to further develop this technology appropriately. Most courses currently available for neurosurgeons to learn about MgLTA are industry-sponsored. This Practical Clinic will allow neurosurgeons using the technology to more openly discuss their experiences using their various systems and how these systems may be advantageous and/or limit their practices.
- Identify possible uses and limitations of LITT in the treatment of tumors.
- Recognize possible uses and limitations of LITT in the treatment of epilepsy.
- Compare and contrast the differences in available LITT systems.